Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis - A pilot study

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Arasaradnam, Ramesh P ^a,b   Westenbrink, Eric ^a   McFarlane, Michael J ^b   Harbord, Ruth ^a   Chambers, Samantha ^b   O'Connell, Nicola ^b   Bailey, Catherine ^b   Nwokolo, Chuka U ^b   Bardhan, Karna D ^c   Savage, Richard ^a   Covington, James A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5,7 CYCLOOCTATETRAENE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

ADULT; ARTICLE; CASE CONTROL STUDY; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FIELD ASYMMETRIC ION MOBILITY SPECTROMETRY; GLUTEN FREE DIET; HUMAN; ION MOBILITY SPECTROMETRY; IRRITABLE COLON; MACHINE LEARNING; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; NON INVASIVE MEASUREMENT; PILOT STUDY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINALYSIS; IRRITABLE BOWEL SYNDROME; URINE;

ADULT; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; VOLATILE ORGANIC COMPOUNDS;

EID: 84908032161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107312     Document Type: Article

References (32)

1. NICE (2009) Coeliac disease: recognition and assessment of Coeliac disease. NICE Clinical Guideline 86.
2. Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schappi MG (2013) Diagnostic accuracy of a new point-of-care screening assay for celiac disease. World J Gastroenterol. 21; 19(31): 5111-7.
3. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, et al. (2000) Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 95(4): 999-1007.
4. Harrison E, Li KK, Petchey M, Nwokolo CU, Loft D, et al. (2013) Selective measurement of anti-tTG antibodies in coeliac disease and IgA deficiency: an alternative pathway. Postgrad Med J. 89(1047): 4-7.
5. Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, et al. (2006) Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol. 18(5): 493-501.
6. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McALindon ME, et al. (2008) What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 6(3): 314-20.
7. Vahedi K, Mascart F, Mary JY, Laberenne JE, Bouhnik Y, et al. (2003) Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol. 98(5): 1079-87.
8. Dahle C, Hagman A, Ignatova S, Strom M (2008) Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase. Aliment Pharmacol Ther. 32(2): 254-60.
9. McGowan KE, Lyon ME, Butzner JD (2008) Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem. 54(7): 1203-9.
10. Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, et al. (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer. 10; 103(4): 542-51.
11. De Meij TG, Ben Larbi I, van der Schee MP, Lentferink YE, Paff T, et al. (2014) Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int. J. Cancer. 134(5): 1013-1255.
12. Arasaradnam RP, Ouaret N, Thomas MG, Quaraishi N, Heatherington E, et al. (2013) A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease. Inflamm Bowel Dis. Apr; 19(5): 999-1003.
13. Covington JA, Wedlake L, Andreyev J, Ouraet N, Thomas MG, et al. (2012) The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study. Sensors (Basel). Sep 26; 12(10): 13002-18.
14. Covington JA, Westenbrink EW, Ouaret N, Harbord R, Bailey C, et al. (2013) Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel). 6; 13(9): 11899-912.
15. Arasaradnam RP, Covington JA, Harmston C, Nwokolo CU (2014) Next generation diagnostic modalities in gastroenterology - gas phase volatile compound biomarker detection. Alimentary Pharmacology and Therapeutics. 39(8): 780-789.
16. Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, et al. (2007) Volatile organic compounds from faeces and their potential for diagnosis of gastrointestinal disease. FASEB J. 21: 1675-88.
17. Probert CS, Ahmed I, Khalid T, Johnson E, Smith S, et al. (2009) Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver disease. J Gastroninestin Liver Dis. 18: 337-43.
18. Arasaradnam RP, Pharaoh MW, Williams GJ, Nwokolo CU, Bardhan KD, et al. (2009) Colonic fermentation-more than meets the nose. Med Hypotheses. 73(5): 753-6.
19. Arasaradnam R, Quraishi N, Kyrou I, Nwokolo CU, Kumar S, et al. (2011) Insights into 'Fermentonomics': Evaluation of volatile organic compounds (VOCs) in human disease using an Electronic 'e' Nose. J Med Eng Technol. Feb; 35(2): 87-91. Epub 2011 Jan 4.
20. Arasaradnam RP, Ouaret N, Thomas MG, Gold P, Quraishi MN, et al. (2012) Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'. J Med Eng Technol. Oct; 36(7): 333-7.
21. Buszewski B, Kesy M, Ligor T, Amann A (2007) Human exhaled air analytics: biomarkers of disease. Biomed Chromatogr. 21: 533-66.
22. Arasaradnam RP, Bardhan KD (2010) Bioactive foods and Extracts - Cancer treatment and prevention. Taylor Francis, New York.
23. Hastie T, Tibshirani R, Friedman J, Hastie T, Friedman J, et al (2009). The elements of statistical learning (Vol. 2, No. 1). New York: Springer.
24. Chui CK (1992) An Introduction to Wavelets. San Diego: Academic Press.
25. Murphy KP (2012) Machine learning: a probabilistic perspective. MIT press.
26. Stinson M, Ezra D, Hess WM, Strobel G (2003) An endophytic Gliocladium sp. of Eucryphia cordifolia producing selective volatile antimicrobial compounds. Plant Science Oct; 165(4): 913-22.
27. Ting ASY, Mah SW, Tee CS (2011) Detection of potential volatile inhibitory compounds produced by endobacteria with biocontrol properties towards Fusarium oxysporum f. sp. cubense race 4. World J Microbiol Biotechnol Feb; 27(2): 229-35.
28. Amann A, Smith D (2013) Volatile Biomarker: Non-Invasive Diagnosis in Physiology and Medicine. Chapter 22: Volatile Organic Compounds Found in Urine and Stool: 411. Elsevier.
29. Caminero A, Herrán AR, Nistal E, Perez-Andres J, Vaquero A, et al. (2014) Diversity of the cultivable human gut microbiome involved in gluten metabolism: Isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. 88(2): 309-19.
30. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, et al. (2010) Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. Feb 24; 10: 63.
31. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y (2009) Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 62(3): 264-9.
32. Nadal I, Donat E, Ribes-Koninckx C, Fernandez-Murga ML, Sanz Y (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 56(12): 1669-74.